Could Stem Cells Help End the Pandemic?

MARCH 5, 2021


  • Stem cell therapies have advanced in recent years, particularly in the field of regenerative medicine.
  • The COVID-19 pandemic triggered a race for biotechnology and pharmaceutical companies seeking applications for both treatments and a cure.
  • Stem cell therapy has been proposed as a potential treatment for COVID-19 patients with severe symptoms.
  • While COVID-19 vaccine/treatment stocks have been popular, investors should remain mindful of relevant ESG risks associated with proposed stem cell applications.

Start typing and press Enter to search